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Background: BMP-induced chemotaxis of mesenchymal progenitors is fundamental for vertebrate development,
disease and tissue repair. BMP2 induces Smad and non-Smad signalling. Whereas signal transduction via Smads lead
to transcriptional responses, non-Smad signalling induces both, transcriptional and immediate/early non-transcriptional
responses. However, the molecular mechanisms by which BMP2 facilitates planar cell polarity, cortical actin
rearrangements, lamellipodia formation and chemotaxis of mesenchymal progenitors are poorly understood.
Our aim was to uncover the molecular mechanism by which BMP2 facilitates chemotaxis via the BMP2-dependent
activation of PI3K and spatiotemporal control of PIP3 production important for actin rearrangements at the
mesenchymal cell cytocortex.
Results: We unveiled the molecular mechanism by which BMP2 induces non-Smad signalling by PI3K and the role
of the second messenger PIP3 in BMP2-induced planar cell polarity, cortical actin reorganisation and lamellipodia
formation. By using protein interaction studies, we identified the class Ia PI3K regulatory subunit p55γ to act as a
specific and non-redundant binding partner for BMP receptor type II (BMPRII) in concert with the catalytic subunit
p110α. We mapped the PI3K interaction to a region within the BMPRII kinase. Either BMP2 stimulation or increasing
amounts of BMPRI facilitated p55γ association with BMPRII, but BMPRII kinase activity was not required for the
interaction. We visualised BMP2-dependent PIP3 production via PI3K p55γ/p110α and were able to localise PIP3 to
the leading edge of intact cells during the process of BMP2-induced planar cell polarity and actin dependent
lamellipodia formation. Using mass spectrometry, we found the highly PIP3-sensitive PH-domain protein LL5β to
act as a novel BMP2 effector in orchestrating cortical actin rearrangements. By use of live cell imaging we found that
knock-down of p55γ or LL5β or pharmacological inhibition of PI3K impaired BMP2-induced migratory responses.
Conclusions: Our results provide evidence for an important contribution of the BMP2-PI3K (p55γ/p110α)- PIP3-LL5β
signalling axis in mesenchymal progenitor cell chemotaxis. We demonstrate molecular insights into BMP2-induced PI3K
signalling on the level of actin reorganisation at the leading edge cytocortex. These findings are important to better
understand BMP2–induced cytoskeletal reorganisation and chemotaxis of mesenchymal progenitors in different
physiological or pathophysiological contexts.
Keywords: Actin, BMP, BMP receptor, Chemotaxis, LL5beta, Migration, p110alpha, p55gamma, PHLDB2, PIK3R3* Correspondence: Knaus@zedat.fu-berlin.de
†Equal contributors
Institute for Chemistry and Biochemistry, Freie Universität Βerlin, 14195 Berlin,
Germany
© 2014 Hiepen et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Hiepen et al. BMC Biology 2014, 12:43 Page 2 of 17
http://www.biomedcentral.com/1741-7007/12/43Background
Gradients of bone morphogenetic proteins (BMPs) act
as mesenchymal guidance cues during development,
disease and tissue repair by molecular mechanisms that
remain poorly defined [1]. In particular, the directional
migration (chemotaxis) of neural crest cells, bone mar-
row stromal cells and endothelial cells along gradients of
BMP2 has been reported [2-5]. BMPs signal through
binding to cell surface hetero-oligomeric receptor com-
plexes comprising type I (BMPRI) and type II (BMPRII)
receptors [6]. Activated BMP receptor complexes induce
canonical-Smad and non-Smad signalling cascades [7].
Activation of the type I receptor kinase by the type II re-
ceptor kinase induces phosphorylation and thus nuclear
translocation of Smad1/5/8, leading to transcription of
Smad-dependent target genes [8].
Whereas the molecular basis of canonical Smad signal-
ling and its role in gene transcription is well explored, the
molecular activation mechanism and the cellular functions
of the non-Smad pathways, which rather act directly and
independently of gene transcription, are poorly under-
stood. In particular, the molecular mechanism of BMP-
induced phosphatidylinositol 3-kinase (PI3K) activation,
its signalling route and cellular function are poorly charac-
terised. In recent years, several studies unveiled a require-
ment of PI3K for BMP2-induced migration of various cell
types with mesenchymal origin by yet unknown mecha-
nisms [9-11].
Here, for the first time, we addressed the molecular acti-
vation mechanism of BMP2-induced PI3K signalling in
undifferentiated mesenchymal progenitor cells and the
role of the lipid-product of PI3K, the membrane-bound
second messenger PtdIns-3, 4, 5-triphosphate (PI (3, 4, 5)
P3; hereafter referred to as PIP3) in BMP2-induced actin
reorganisation.
Class Ia PI3Ks are dimeric lipid kinases composed of
one out of five possible regulatory subunits encoded by
Pik3r1 (encoding splice isoforms p85α, p55α and p50α),
Pik3r2 (p85β) or Pik3r3 (p55γ) [12,13]. The regulatory
subunit is bound by one of three catalytic subunits,
termed p110, encoded by Pik3ca (p110α), Pik3cb (p110β)
or Pik3cd (p110δ) [14]. Catalytic activity is initiated upon
regulatory subunit Src homology 2 (SH2) domain binding
to phospho-tyrosine (pTyr) residues within a specific pep-
tide context [15]. Thereafter, activated PI3K phosphory-
lates the 3-hydroxyl group of PtdIns-4, 5-bisphosphate
(PIP2) to produce the second messenger PIP3. PIP3 re-
cruits Pleckstrin homology (PH) domain-containing regu-
lators to the inner plasma membrane. One main PI3K
effector is protein kinase B (PKB/Akt) [16]. Besides Akt,
PH-domain-containing cytoskeletal regulators sense PIP3
and mediate cortical actin dynamics at the so-called lea-
ding edge cytocortex. As such, the PH-like domain family
B member 2 (Phldb2, hereafter referred to as LL5β) actsas a sensitive PIP3 effector during the establishment of pla-
nar cell polarity (PCP), lamellipodia formation, protrusion
and subsequent chemotaxis [17]. LL5β orchestrates actin
rearrangements through tethering actin cross-linkers of
the filamin family to PIP3-rich plasma membranes [17-19].
In this study, we identified that the PI3K regulatory
subunit p55γ functions as a novel BMPRII-interacting
protein. It acts in concert with p110α to mediate BMP2-
induced PIP3 production and hence cortical actin re-
arrangements. We visualised that BMP2-induced PI3K
activity produces PIP3 at the cytocortex, which subsequently
recruits LL5β to orchestrate cortical actin crosslinking. Ei-
ther knock-down of p55γ or LL5β or pharmacological
inhibition of PI3K impaired BMP2-induced directional cell
migration. Hence our study presents the first insights into
the molecular activation and regulation mechanism by
which BMP2 facilitates PI3K activity and the cytocortical
signalling events leading to cortical actin reorganisation,
PCP and chemotaxis. These molecular details are im-
portant to better understand BMP2-induced chemotaxis
of mesenchymal progenitor cells during vertebrate devel-
opment, tissue repair or disease.
Results
BMP2-induced PI3K signalling is required for chemotaxis
To visualise BMP2-induced chemotaxis of multipotent
mesenchymal progenitor cells, we used a 2D in vitro
setup, which allowed the application of a linear BMP2 gra-
dient and concomitant tracking of migrating C2C12 cells
over time. Undifferentiated C2C12 myoblasts are multipo-
tent and represent a common tool for investigating BMP
signalling and its cellular functions. Non-stimulated cells
displayed basal random migration, while application of a
linear BMP2 gradient resulted in an overall gain in migra-
tory directionality towards the source of BMP2 and a gain
in migration distance. C2C12 cell chemotaxis was blocked
upon pre-incubation with the PI3K p110α selective inhibi-
tor PI103 (Figure 1A). Trans-Golgi staining of Syntaxin 6
in migrated C2C12 cells revealed PCP with the trans-
Golgi aligned towards the leading edge, which was going
with the direction of chemotaxis. By contrast, the Golgi
were aligned randomly when cells were not stimulated or
allowed to undergo BMP2-induced chemotaxis in the
presence of PI103 (Figure 1B).
PI3K regulatory subunit p55γ interacts with the long and
short forms of BMPRII
To address the molecular mechanism of BMP-induced
directional cell migration, we followed some promising
hits from a proteomics-based mass spectrometry screen
designed to identify novel BMPRII interacting proteins
[20]. Among those proteins not published earlier was
PI3K regulatory subunit p55γ (Figure 2A, p55γ specific
peptides in yellow) that co-immunoprecipitated with
Figure 1 BMP2 induces chemotaxis of multipotent mesenchymal C2C12 mouse myoblasts. (A) Trajectories of multipotent mouse
mesenchymal C2C12 cells migrating in a 2D chemotaxis chamber over period of 16 hours exposed to a linear BMP2 gradient compared
to non-stimulated control or in the presence of the PI3K p110α selective inhibitor PI103 (8 nM). The gradient was produced by application of
BMP2 to the upper reservoir. It was allowed to generate a linear concentration profile with a maximum concentration of approximately 10 nM reaching
the cells on the edge of the observation area as described by the manufacturer. (B) Syntaxin 6 and DAPI stainings of C2C12 cells after BMP2-induced
chemotaxis compared to non-stimulated control or PI103 [8 nM] pre-treatment. The location of the depicted cells within the chemotaxis chamber
is indicated. Scale bar represents 20 μm. (2D) two dimensional; (BMP2) Bone Morphogenetic Protein 2; (PI3K) Phosphoinositide 3-kinase;
(p110α) Class I PI3K catalytic subunit alpha; (DAPI) 4',6-diamidino-2-phenylindole.
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form (SF). BMPRII exists in mouse myoblast C2C12
cells in two splice variants, the BMPRII-long form
(BMPRII-LF) and BMPRII-SF [21], with BMPRII-LF
abundant in most other cell types. To first investigate
the interaction site for p55γ in BMPRII, we performed
co-immunoprecipitation studies in HEK293T cells
upon overexpression of different BMPRII truncations
(TCs) (Figure 2B) that lack parts of the C-terminal tail
unique for BMPRII-LF. Upon p55γ precipitation we con-
firmed an interaction with wild-type (wt) BMPRII-LF and
all BMPRII truncations (TC3 to TC8) as well as
BMPRII-SF (Figure 2B). To validate the interaction of
p55γ with both splice forms, we performed studies in
C2C12 cells by pull-down of either endogenous p55γ or
endogenous p85α (for antibody validation see Additional
file 1: Figure S1A). We then probed for co-precipitated en-
dogenous BMPRII by use of a BMPRII-specific antibody
recognising an extracellular epitope (Figure 2C). As shown
in lanes 1 to 3, endogenous p55γ, but not p85α (lanes 4 to
6), co-immunoprecipitated with BMPRII-LF and BMPRII-SF, with the receptor association to p55γ increasing over
time during BMP2 treatment. Furthermore, we detected
the class Ia catalytic subunit p110α in p55γ precipitates,
suggesting that BMP2 activates PI3K heterodimers of
p55γ and p110α (Figure 2C, lower panel lanes 1 to 3).
Since co-immunoprecipitation in C2C12 cells confirmed a
p55γ but not p85α interaction with BMPRII, we compared
their respective co-localisation patterns in intact cells. For
this, C2C12 cells were transiently transfected with Human
influenza hemagglutinin (HA)-tagged BMPRII-LF and
stained by use of antibodies binding to regulatory subunits
and the HA-tag. Epifluorescence microscopy revealed
strong co-localisation of p55γ, but only partial co-
localisation of p85α, with BMPRII-LF within C2C12
cell protrusions (Figure 2D). Co-localisation was
quantified defining a fixed region of interest. Mean
Pearson’s coefficient of three sets of independent
experiments revealed 0.933 ± 0.092 for co-localisation
of p55γ and 0.741 ± 0.093 for p85α with BMPRII-LF
(Additional file 1: Figure S1B). We then con-
firmed that p110α indeed specifically binds to
Figure 2 PI3K regulatory subunit p55γ interacts with BMPRII and p110α. (A) p55γ-specific peptides obtained after GST-BMPRII-pull-down from
C2C12 lysates [20] are shown in yellow. (B) Scheme depicting BMPRII and truncations, including all tyrosines (black lines) and the ones serving as
putative p55γ-SH2 domain binding sites (*). Tyrosines identified by alignment with known SH2 binding peptides (*) and oriented peptide library technique
(**). Lines indicate localisation of 24 intracellular tyrosines in BMPRII. On the right, lanes 1 to 8 show input controls (top) and co-immunoprecipitation of
BMPRII-LF, -SF or TC3-8 with p55γ from transfected HEK293T cells. The expected molecular weights of BMPRII and truncations are marked by white
arrowheads. (C) Co-immunoprecipitation of endogenous BMPRII-LF and -SF (black arrowheads) with endogenous p55γ, but not p85α upon stimulation
with 10 nM BMP2 for indicated time. The depicted western blots are representative of three independent experiments. (D) Immunocytochemical staining
of C2C12 cells displaying co-localisation of endogenous p55γ, but not p85α, with overexpressed HA-tagged BMPRII-LF. Enlarged region of interest depicts
co-localisation of p55γ but not p85α (green) with HA-tagged BMPRII-LF (red) at the cell periphery. Scale bar: 10 μm. (E) Co-immunoprecipitation from
C2C12 lysates of endogenous BMPRII and endogenous p110α upon BMP2 stimulation for indicated time. (F) BMP2-induced tyrosine phosphorylation of
BMPRII-LF. HEK293T cells transfected with HA-tagged BMPRII-LF were treated with 10 nM BMP2 for indicated time and subjected to immunoprecipitation
with anti-HA antibody. Input controls of HA-tagged BMPRII-LF and BMP2-induced Smad 1/5/8 phosphorylation kinetics are shown (upper two panels).
Fourth panel indicates BMPRII tyrosine phosphorylation through incubation of α-HA precipitates with pan anti-pTyr antibody. Dotted lines in F and B
indicate deletion of non-relevant lanes. (See also Additional file 1: Figure S1C). (ECD) extracellular domain; (KD) kinase domain; (LF) long form; (SF) short
form; (TC) truncation; (IgG) immunoglobulin G.
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co-immunoprecipitated BMPRII in a BMP2-dependent
manner (Figure 2E, lane 4). Together, these data dem-
onstrate that p55γ specifically binds to BMPRII irre-
spective of the presence of the C-terminal tail and is
part of a p110α-containing PI3K complex.BMPRII becomes tyrosine phosphorylated in a BMP2-
dependent manner
Class Ia PI3Ks interact with activated growth factor recep-
tors via pTyr motifs recognised by the SH2 domains of
the regulatory subunit [22]. BMPRII is a serine/threonine
kinase and its tyrosine phosphorylation has not been
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BMPRII-LF contains 24 tyrosines; the majority of ty-
rosines are located within the kinase domain, a few in
the C-terminal tail and none in the juxtamembrane region
preceding the kinase domain (Figure 2B). An in silico
alignment of the BMPRII cytosolic domain with known
SH2 domain-binding peptides (Figure 2B, marked with *)
[15] and analysis using ScanSite oriented peptide library
technique (marked with **) [23] identified five poten-
tial tyrosines that could act as SH2 domain docking sites
(black lines indicate locations of all other BMPRII tyrosines
in cytosolic domains). To first analyse BMP2-dependent
tyrosine phosphorylation of BMPRII, we transfected
HEK293T cells with HA-tagged BMPRII-LF, followed by
immunoprecipitation using anti-HA antibody. BMPRII
tyrosine phosphorylation was investigated using an anti-
pTyr antibody. We found basal Tyr phosphorylation of
BMPRII-LF in starved cells (Figure 2F, lower panel, lane
1), which increased upon 15 to 60 minutes stimulation
with BMP2 (lanes 3 to 6). This kinetic profile resembles
Smad1/5/8 phosphorylation by activated receptor com-
plexes (Figure 2F, upper panel). A BMP2-dependent Tyr
phosphorylation of endogenous BMPRII was also con-
firmed using C2C12 cells upon pull-down of endogenous
BMPRII after 60 minutes’ BMP2 stimulation compared to
non-stimulated control (Additional file 1: Figure S1C,D,E).
A vice versa approach by performing a pTyr pull-down
upon BMP2 stimulation on BMPRII-LF-HA transfected
HEK293T cells and subsequent blotting using anti- HA
antibody also confirmed the tyrosine phosphorylation of
BMPRII (Additional file 1: Figure S1D). The pTyr specifi-
city of the antibody was proven by sodium orthovanadate
treatment of cells and additionally by dephosphorylation
using Antarctic phosphatase treatment of the membrane
after western blotting with pTyr antibody (Additional
file 1: Figure S1E). To identify particular phosphorylated
tyrosine residues on BMPRII, respective mass spectrom-
etry approaches have to be performed in the future. To-
gether, these results confirm that BMPRII is tyrosine
phosphorylated in a BMP2-dependent manner and pro-
vides the required features to associate with p55γ.
BMPRII-kinase activity is dispensable but the presence of
BMPRI enhances BMPRII-p55γ interaction
BMP receptor complexes comprising BMPRI and BMPRII
oligomerise by different modes with the BMP induced
signalling complex (BISC) to induce non-Smad signalling
[24,25]. BISCs are formed through a BMP2-induced recruit-
ment of BMPRII to ligand-bound BMPRI and this is re-
quired for the induction of non-Smad pathways [25,26]. To
investigate the contribution of BMPRII kinase activity in
the BMPRII-p55γ complex, we first investigated the binding
properties of flag-tagged p55γ to HA-tagged wt BMPRII-LF
compared to binding to a kinase-dead mutant (BMPRII-LF-K230R) [27]. Upon overexpression in HEK293T cells and
precipitation of p55γ, we detected both wt BMPRII-LF and
BMPRII-LF-K230R in p55γ precipitates (Figure 3A, lanes 1
and 2). Intriguingly, we found the interaction of p55γ with
wt BMPRII-LF and BMPRII-LF-K230R was further facili-
tated by concomitant overexpression of BMPRIb (Figure 3A,
lanes 3 and 4). By contrast, BMPRIb alone or the corre-
sponding BMPRI kinase-dead mutant (BMPRIb-K231R)
did not co-immunoprecipitate with p55γ (Additional file 2:
Figure S2). These data prove that the kinase activity of
BMPRII is dispensable for association with p55γ, whereas
the availability of BMPRI critically influences the inter-
action of p55γ to BMPRII. To elucidate further whether
BMPRII-LF and BMPRII-LF-K230R are equally potent in
activating signalling by PI3K, we expressed increasing
amounts of each receptor in HEK293T cells followed by
detection of phospho-Akt threonine 308 (Thr308). In the
presence of BMP2, both wt BMPRII-LF and BMPRII-LF-
K230R significantly promoted Akt phosphorylation at
Thr308 as the amount of DNA transfected was increased
(Figure 3B). As expected, expression of BMPRII-LF-K230R
resulted in a dominant negative effect on the BMP2-
induced Smad signalling, seen by a decreased Smad1/5/8
phosphorylation (Figure 3B, lanes 4 to 6).
BMP2-induced PI3K signalling is specifically mediated via
p55γ
We next characterised the dynamics of BMP2-induced
PI3K signalling in C2C12 cells, focusing on main PI3K-
PIP3 effectors to show definitively that p55γ is required
for PI3K signalling. We detected immediate (after 5 -
minutes; Figure 4A, lanes 2 and 3) phosphorylation of
3-phosphoinositide-dependent kinase-1 (PDK1), coincid-
ing with phosphorylation of Akt at Thr308; phosphoryl-
ation of Akt at Ser473 was detected after 15 minutes
(Figure 4A, lanes 10 to 13). Phosphorylation of several ty-
rosines in PI3K regulatory subunits by PI3K agonists has
been previously demonstrated and phosphorylation of the
inter-SH2 domain (iSH2) was suggested to mediate recep-
tor specificity [28] and p110 catalytic activity [29]. We
probed for phosphorylation of PI3K regulatory subunit
iSH2 using a pTyr-specific antibody, which detects a
conserved Tyr within the iSH2 domain. This antibody
has been previously used to probe for PI3K activation
in response to Src [30]. To discriminate between BMP2
effects on iSH2 Tyr-phosphorylation of p55γ (Tyr199) and
p85α (Tyr458), equal amounts of flag-tagged p55γ and
HA-tagged p85α were expressed in HEK293T cells. BMP2
stimulation resulted in a time-dependent phosphoryl-
ation of p55γ-Tyr199 after 15 minutes, whereas p85-
phosphorylation appeared less affected (Figure 4B).
Subsequently, we investigated whether BMP2-induced
PI3K signalling is p55γ-dependent. For this, we per-
formed siRNA-mediated knock-down of endogenous p55γ
Figure 3 BMPRII-kinase activity is dispensable but BMPRI enhances the p55γ interaction with BMPRII. (A) Co-immunoprecipitation of
HA-tagged BMPRII-LF or kinase-dead BMPRII-K230R-HA with flag-tagged p55γ in the presence or absence of BMPRIb-HA from transiently
transfected HEK293T cells. Left panel depicts quantification of co-immunoprecipitated BMPRII relative to the amount of flag-tag mediated
precipitation of p55γ. Upper panel shows input controls for BMPRII-HA, BMPRIb-HA and p55γ-flag. Lower panel depicts co-immunoprecipitation of
BMPRII-HA with blots taken with long (upper lanes) and short (lower lanes) exposure times. White arrowheads indicate the migration heights of BMPRII,
BMPRIb and p55γ. Dotted lines indicate deletion of non-relevant lanes from the same blot. (B) Activation of PI3K signalling by transient expression of
BMPRII and BMPRII-K230R. Upper panel shows the effect of increasing amounts of BMPRII-LF or BMPRII-K230R transfected cells against β-galactosidase
(β-gal) on the activation of phospho-Akt Thr308 in HEK293T cells. Experiments were carried out in the presence of 10 nM BMP2, which was added
60 minutes prior to cell lysis. Note the dominant negative effect of BMPRII-LF-K230R on pSmad1/5/8 but not phospho-Akt Thr308. Lower
panel shows quantification of phospho-Akt Thr308 intensities relative to GAPDH. Error bars represent standard deviation from three independent
experiments. P-values from one-way analysis of variance with post-hoc Bonferroni-test are indicated. (See also Additional file 2: Figure S2.)
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expected, siRNA-mediated knock-down of p55γ signifi-
cantly impaired BMP2-induced Akt phosphorylation
at Thr308 compared to a scrambled siRNA control
(Figure 4C). In addition, we investigated the effect of
p55γ overexpression on BMP2-induced Akt phosphoryl-
ation. We found that p55γ overexpression exerts a domin-
ant negative effect on BMP2-induced Akt phosphorylation,
a phenomenon that has been previously reported to under-
lie an unbalanced ratio between the regulatory and cata-
lytic subunits [31] (Figure 4D). Taken together, these
results demonstrate that p55γ specifically links BMP2 with
the activation of PI3K signalling.
BMP2-induced PIP3 production is dependent on p55γ
We then analysed whether BMP2-induced PIP3 produc-
tion requires p55γ by performing a PI3K activity assay.
For this, C2C12 cells were stimulated with BMP2 follow-
ing pull-down of p55γ or p85α. Subsequently, we analysedin vitro lipid kinase activity of precipitated complexes
using a competitive ELISA system (Figure 5A). Precipi-
tates of p55γ revealed increased PIP3 production after
BMP2 stimulation for 15 minutes (lane 2; decreased
absorbance at 450 nm), which further increased at the
60-minute time-point (lanes 2 to 4). By contrast, pre-
treatment with the PI3K inhibitor LY-294002 or pull-
down of p85α gained PIP3 levels comparable to levels in
non-stimulated p55γ precipitates (Figure 5A, lanes 5
and 6). The pull-down of p85α only resulted in ele-
vated PIP3 levels when cells were stimulated with insulin
(100 nM). This further underlines the role of p85α in other
pathways, but not BMP signalling (Figure 5A, lane 7). Pull-
down controls for both regulatory subunits and the co-
immunoprecipitated p110α are shown (Figure 5A, lower
panel). The potency of small molecule inhibitors in inter-
fering with BMP2-induced PI3K signalling was tested by
the application of Wortmannin (25nM) (Additional file 4
Figure S4) and LY-294002 (10 μM), the class Ia selective
Figure 4 BMP2-induced PI3K signalling is specifically mediated via p55γ. (A) Phospho-kinetics of PI3K effector proteins in C2C12 upon
stimulation with 10 nM BMP2 for the indicated time. Phosphorylation of PDK1 (Ser241), Akt (Thr308) and Akt (Ser473) was analysed.
(B) BMP2-dependent tyrosine phosphorylation at the inter-SH2 domain of PI3K regulatory subunits p55γ and p85α. HEK293T cells were
transfected with equal amounts of p55γ-flag and p85α-HA and stimulated with 10 nM BMP2 for the indicated time. Upper panel depicts BMP2-
dependent phosphorylation of conserved Tyr458 of p85α (see arrowheads, double band at approximately 100 kDa) corresponding to Tyr199
of p55γ (see arrowhead at approximately 55 kDa). The detected signals migrated accordingly to the signals of p85α-HA and p55γ-flag in the
expression control (arrowheads, lower panel). (C) Knock-down of p55γ reduces BMP2-induced Akt-Thr308 phosphorylation of C2C12 cells upon
60 minutes’ stimulation with BMP2. The relative phospho-Akt-Thr308 to GAPDH levels were determined. (D) Overexpression of p55γ-flag in
C2C12 cells reduces BMP2-induced Akt-Thr308 phosphorylation upon 60 minutes’ stimulation with BMP2. The relative phospho-Akt-Thr308 to
GAPDH levels were determined. For experiments C and D: error bars represent standard deviation from three independent experiments.
P-values from one-way analysis of variance with post-hoc Bonferroni-test are indicated. (See also Additional file 4: Figure S4.)
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inhibitor LDN-193189 (0.5 μM) (Additional file 5: Figure
S5A).
PIP3 and PIP3 effectors localise to BMP2-induced cortical
actin-rich lamellipodia
The p55γ-dependent production of PIP3 led us to the hy-
pothesis that BMP2-induced cytoskeletal rearrangements
utilise membrane-anchored PIP3 to target actin-
reorganising proteins to the cytocortex. Staining with PIP3-
specific antibody revealed increased PIP3 accumulationwithin dorsal ruffles and lamellipodial protrusions upon
BMP2 stimulation (Figure 5B). Consistent with this, pre-
incubation with PI103 blocked the BMP2-dependent trans-
location of the GFP-tagged PH-domain of Akt (Additional
file 5: Figure S5B) and the localisation of phospho-Akt and
phospho-PDK1 to BMP2-induced actin-rich lamellipodia
(Additional file 5: Figure S5C). To characterise the dynam-
ics of PIP3-enriched lamellipodia, we performed live-cell
imaging combined with differential interference contrast
microscopy. Application of BMP2 to living cells induced
dynamic cytoskeletal rearrangements and dorsal ruffling
Figure 5 BMP2-induced PIP3 production is p55γ-dependent and localises to cortical actin during lamellipodia formation.
(A) BMP2-dependent PIP3 production as detected by PI3K activity ELISA (upper panel). C2C12 cells were stimulated with respective ligands
and inhibitors for the indicated times and lysates were subjected to pull-down of endogenous p55γ or p85α as shown. Precipitates were
subjected to an in vitro kinase reaction and competitive ELISA was used to detect the amount of PIP3 produced by BMP2-induced PI3K activity.
Low absorbance at 450 nm indicates high levels of PIP3. To prove the presence of catalytic p110α in PI3K regulatory subunit pull-down, bead lysates
of all three assays were pooled and subjected to detection of p55γ, p85α and p110α protein respectively (lower panel). Error bars represent standard
deviation from three independent experiments. (B) Immunocytochemical detection of PIP3 in BMP2 (10 nM) stimulated C2C12 cells by use of
PIP3-specific antibody. The cortical region of PIP3 accumulation is indicated by the white arrow. (C) Differential interference contrast (DIC)
microscopy of membrane ruffles at dorsal (white arrow) regions of the leading edge of C2C12 cells stimulated with 10 nM BMP2. In B
and C, the lower boxes depict magnifications of the regions of interest indicated by white squares (upper boxes). Scale bars represent
20 μm. (D) Phalloidin and Synatxin 6 staining indicating trans-Golgi position facing the cortical actin-rich leading edge of C2C12 cells
stimulated with 10 nM BMP2 for the indicated time. Scale bars represent 10 μm. (See also Additional file 5: Figure S5).
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protrusion phase (30 to 90 minutes) (Figure 5C,
Additional file 6). This response was accompanied by an
overall change in leading edge directionality (Figure 5C,
black arrows). Subsequent actin staining uncovered
BMP2-induced lamellipodia enriched in cortical actin.
Concomitant staining using an anti-Syntaxin 6 antibody
indicated that the Golgi apparatus realigned upon BMP2
stimulation to face the cells leading edge (Figure 5D). We
also found that in C2C12 cells, endogenous BMPRII-LF
localises to BMP2-induced dorsal ruffles independent ofFigure 6 The PIP3-binding protein LL5β localises to BMP2-induced co
Coomassie Blue staining of protein precipitates gained by precipitation of P
panel shows LL5β detection (approximately 160 kDa) by western blot. LL5β
(B) LL5β-specific peptides (marked in yellow) as identified by mass spectro
(C) Immunocytochemical stainings of endogenous LL5β and actin in C2C1
co-localisation of LL5β with cortical actin in BMP2-induced cell protrusions
(D) PI103 pre-treatment blocks BMP2-induced co-localisation of LL5β with
minutes in the presence of DMSO or 8 nM PI103 respectively. The magnifie
actin. Scale bars represent 20 μm.new protein synthesis as proven by cyclohexamide treat-
ment but also independent of canonical Smad signalling
using LDN193189 (Additional file 5: Figure S5D).
The PIP3-binding protein LL5β localises to BMP2-induced
cortical actin-rich lamellipodia
Regulators of cortical actin that transduce BMP2 signals in
a PIP3-dependent manner are largely unknown. To identify
putative BMP2-dependent and PIP3-sensitive cytoskeletal
regulators, we performed pull-downs in C2C12 cell lysates
using PIP3-coated beads following mass spectrometry. Wertical actin-rich lamellipodia. (A) Upper panel shows colloidal
IP2-, PIP3-coated and control beads from C2C12 cell lysates. Lower
binds to PIP3 (lane 3) but not PIP2 or control beads (lanes 1 and 2).
metry upon precipitation of PIP3-coated beads from C2C12 cell lysates.
2 cells upon 45 minutes’ stimulation with 10 nM BMP2. Arrow indicates
at the C2C12 cell leading edge (magnified region of interest).
cortical actin. C2C12 cells were stimulated with 10 nM BMP2 for 45
d region of interest depicts the co-localisation of LL5β with cortical
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to PIP3 (Figure 6A), whereas LL5β was absent from PIP2
precipitates and control beads (Figure 6A, specific
peptides for LL5β shown in Figure 6B). LL5β is recruited
by PIP3 to the cytocortex in complex with filamins,
which are major filamentous actin (F-actin) cross-
linkers [19]. To prove that LL5β is involved in BMP2-
dependent cortical actin rearrangements, we first analysed
its sub-cellular localisation. In resting C2C12 cells, LL5β
localised to a cytosolic compartment surrounding the nu-
cleus with a sparse distribution towards the cell cortex
(Figure 6C). Upon BMP2 stimulation, LL5β translocated to
the leading edge cytocortex where it co-localised with cor-
tical actin (Figure 6C). Pre-incubation with PI103 resulted
in loss of BMP2-induced cortical actin filaments and LL5β
remained at cytosolic compartments (Figure 6D). Collect-
ively, these data indicate that the PH-domain protein LL5β
is involved in BMP2-induced actin reorganisation at the
leading edge cytocortex through recruitment by PIP3.
PI3K p55γ/p110α and LL5β are required for BMP2-
induced migration and chemotaxis
To confirm the cellular function of our molecular find-
ings, we investigated whether BMP2 promotes cell mi-
gration, in particular wound closure, which requires a
distinct cell polarity. We found that BMP2 was able to in-
crease the speed of C2C12 wound closure relative to a
non-stimulated control within 14 hours (Figure 7A). Add-
itionally, knock-down of p55γ impaired BMP2-induced
wound closure compared to control transfected cells.
Intriguingly, we found that knock-down of p55γ sig-
nificantly reduced the ability of cells to efficiently enter
the wound in a BMP2-dependent fashion (for quantifica-
tion see Figure 7B). We also investigated the relative
migration of p55γ knock-down cells (red) compared to
scrambled transfected cells (green) by seeding a ‘salt and
pepper’ mix within the same wound. p55γ knock-down
cells displayed considerably impaired polarity and thus re-
duced ability to efficiently enter the wound, instead dis-
playing short trajectories (DiI: fluorescent lipophilic
cationic indocarbocyanine dye/red) compared to control
cells (DiO: fluorescent lipophilic cationic indocarbocya-
nine dye/green; Figure 7C). Next, we performed a trans-
well assay to analyse whether the effect of BMP2-induced
migration becomes more prominent when cells are ex-
posed to a ligand gradient. We found that BMP2 induced
transmigration of C2C12 cells, whereas knock-down of
p55γ or LL5β significantly impaired this response
(Figure 7D).
Collectively, our results demonstrate that the BMPRII-
p55γ interaction is necessary for BMP2-induced class Ia
PI3K activation via the BMPRII-p55γ interaction and
PIP3 production via p110α activity at the leading edge
cytocortex. Moreover, we showed that the BMP2-induced activation of PI3K is critically involved in actin
reorganisation and lamellipodia formation due to the
production of PIP3 and LL5β recruitment. With LL5β,
we found an important PIP3 effector and actin regulator
through its well-described role in tethering filamins to
the cytocortex. p55γ, p110α and LL5β, therefore, critically
influence BMP2-induced chemotaxis with p55γ being a
novel and specific BMPRII-interacting protein required
for chemotactic mesenchymal progenitor cell responses to
BMP2 (Figure 8).
Discussion
Since the initial discovery that BMPs act as chemotactic
guidance cues [32], the molecular mechanism of how
BMPs initiate cell migration and chemotaxis has remained
poorly understood. However, an important role for BMP-
induced cell migration has been demonstrated in several
excellent developmental [2,3,33], repair and disease stud-
ies [9,34]. Here, we aimed to close a gap in the mechanis-
tic molecular understanding of how BMPs in general
activate PI3K signalling in progenitor cells at the molecu-
lar level and how this influences actin reorganisation at
the cytocortex and, hence, lamellipodia formation. We
uncovered major and crucial aspects of the molecular
mechanism by which BMP2 initiates and extends PI3K-
signalling at the plasma membrane, visualised and local-
ised BMP2-induced PIP3 for the first time in intact cells,
and confirmed the requirement of p55γ and LL5β for
BMP2-induced migration and chemotaxis of mesenchy-
mal progenitor cells.
The role of the BMP receptor complex in activating PI3K
signalling
Here, we describe the specific association of the class Ia
PI3K regulatory subunit p55γ with BMPRII for the first
time. This interaction is enhanced by either BMP2 stimu-
lation or the presence of BMPRI whereas the kinase activ-
ity of BMPRII seems dispensable. This observation may
reflect the same mechanism by which BMPRII is incorpo-
rated into BISCs upon stimulation with BMP2 [24], where
the high affinity receptor for BMP2 (BMPRI) recruits
BMPRII into the complex upon BMP2 binding. More-
over, we showed previously that BISC-mediated sig-
nalling and BMPRII recruitment towards BMPRI is
required for non-Smad signalling [25,26]. We therefore
speculate that the BMPRI kinase is required for PI3K acti-
vation whereas BMPRII acts as a scaffolding hub to pro-
vide PI3K for BMPRI-dependent activation mechanisms
that have not yet been defined. This hypothesis is under-
lined by our previous findings of reduced BMP2-induced
Akt phosphorylation upon pharmacological inhibition
of BMPRI kinase activity [35] (see also Additional file 5:
Figure S5A). BMPRI activity seems crucial in mediating
the association of p55γ with BMPRII and, thus, PI3K
Figure 7 BMP2-induced PI3K signalling is important for directional cell migration. (A) C2C12 cell wound closure upon stimulation with 10
nM BMP2 for 14 hours compared to unstimulated control. Lipophilic carbocyanine-dye labelled cells (DiO) are presented in black pseudo-colour.
Scale bar represents 200 μm. Left panel, effect of p55γ knock-down (si-p55γ) on C2C12 cell wound closure compared to scrambled transfected
(si-scr) control. (B) Bar diagram depicting the intensity translocation values for three independent biological replicates for experiments shown in A
using a selective mask filter (for detailed description see Methods and Additional file 7). Error bars represent standard deviation from three
independent experiments. P-values from one-way analysis of variance with post-hoc Bonferroni-test are indicated. (C) Trajectories visualising the
migration of p55γ knock-down (red) and scrambled control (green) C2C12 cells during BMP2-induced wound closure over a period of 12 hours. Scale
bar represents 100 μm. Left panel, equal amounts of si-p55γ (red) and si-scr (green) transfected cells were labelled with DiI or DiO respectively prior to
mixing and seeding. Bar diagram (right panel) summarises the intensity translocation ratios of p55γ knock-down (red) compared to scrambled control
(green) C2C12 cells of 19 replicates analysed with P <0.005 considered statistically significant. (D) Transwell assay of C2C12 cells, transfected with either
si-p55γ or si-LL5β compared to si-scr-transfected C2C12 cells. Cells migrated through an 8 μm porous filter upon stimulation with 10 nM BMP2 for
6 hours in the presence of 0.2% fetal calf serum. The number of cells migrated through the porous filter was counted. Bar diagram represents cell
number counts per optical field. Error bars represent standard deviation from three independent experiments. P-values from one-way analysis of
variance with post-hoc Bonferroni test are indicated.
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Figure 8 Scheme depicting BMP2-induced PI3K signalling via p55γ/p110α and cortical actin rearrangements via PIP3-LL5β filamins in
mesenchymal progenitor cells. Gradients of BMP2 activate the BMP receptor complex and facilitate the association of BMPRII to regulatory
subunit p55γ coupled to class Ia catalytic subunit p110α. The recruitment and activation of PI3K generates the membrane-bound second messenger
PIP3 at the leading edge of cells that are about to establish PCP. PIP3 recruits the PH-domain protein LL5β. LL5β co-recruits and tethers the
actin crosslinker filamin to the leading edge, where it promotes actin polymerisation, crosslinking and subsequent initiation of lamellipodia
formation, extension and protrusion. BMP2, bone morphogenetic protein 2; BMPRI/II, bone morphogenetic protein receptor type I/II;
pSmad1, phospho-Smad1; p55γ, PI3K regulatory subunit p55 gamma; p110α, p110 catalytic subunit p110 alpha; PIP2, phosphatidylinositol
(4,5)-bisphosphate; PIP3, phosphatidylinositol (3,4,5)-triphosphate; LL5β, pleckstrin homology-like domain family B member 2; PH, pleckstrin
homology domain; F-actin, filamentous actin.
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that the high affinity TGF-β receptor type II associated
constitutively with p85α, whereas the low affinity TGF-β
type I receptor only associated with p85α in a ligand-
dependent manner [36]. However, it should be considered
that BMPRI is the high affinity and BMPRII the low affin-
ity receptor for BMP2. This would therefore represent a
mirror-image scenario of PI3K regulatory subunit inter-
action in BMP versus TGF-β receptors. Tyrosine phos-
phorylation of BMPRII is essential for an association with
class Ia PI3K p55γ. Despite its classification as a tyrosine-
like kinase [37], a BMPRII dual kinase activity in vivo
is still speculative and needs to be proven. Our exper-
iments have shown that BMP2 stimulation rapidly induces
BMPRII tyrosine phosphorylation in vitro, comparable
to the kinetics of Smad1/5/8 phosphorylation via a yet
unknown mechanism. Moreover, we identified BMPRII
tyrosine residues that could act as direct putative SH2 do-
main docking sites. Since the interaction site for p55γ
could be mapped to the BMPRII kinase, we speculate that
pTyr motifs in the BMPRII kinase domain are required
for its interaction. However, with the techniques applied
here, we cannot comment on potential intermediate
adaptor proteins or additional tyrosine kinases facilitating
p55γ interaction and BMP2-dependent BMPRII tyrosine
phosphorylation respectively. Along the same line, studies
on the related activin pathway have already suggested the
involvement of additional adaptor proteins that facilitate
the interaction of PI3K regulatory subunits to the activin
receptor ActRII [38]. The tyrosine kinases TrkC [39] andSrc [40] also interact with BMPRII and could thus facili-
tate or mediate its tyrosine phosphorylation at sites re-
quired for the interaction to p55γ. Taken together, the
BMP2-dependent tyrosine phosphorylation of BMPRII
provides the required features for interaction with p55γ,
but further research will be required to unravel the contri-
bution of yet unknown tyrosine kinases and adaptor pro-
teins that may be involved in this interaction.
Exclusive role for p55γ in BMP2-induced PI3K signalling
To date, data regarding unique functions of p55γ are
poor, mainly because it is speculated that the five differ-
ent PI3K regulatory subunits have redundant functions
and may compensate for each other. The data presented
here show that p55γ provides specific functions during
BMP2-induced PI3K signalling. This is underlined by its
exclusive association with BMPRII, its BMP2-dependent
phosphorylation in the iSH2 domain, and the effects on
Akt phosphorylation and cell migration when knock-
down of p55γ was performed. We have confirmed that,
besides p55γ, all other class Ia regulatory subunits,
namely p85α (including splice isoforms p55α and p50α)
and p85β, are detectable at the mRNA level in undifferen-
tiated multipotent C2C12 cells (data not shown). A prom-
inent role for PI3K regulatory subunits during cytoskeletal
rearrangements has already been described, especially
in the context of actin reorganisation [41]. Interestingly,
some studies have proposed that PI3K regulatory subunits
provide non-redundant signalling functions dependent on
their sub-cellular localisation within a cell [42,43]. This is
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teracts and co-localises with BMPRII, predominantly at
the cell periphery. It still remains unclear how BMPRII se-
lectivity for p55γ over p85α is achieved. The p55γ high-
resolution crystal structure has not been determined and
the SH2 and iSH2 domains of human p85α and p55γ
share about 81.1% sequence identity. Based on the data
presented here, we now propose two possible mechanisms
by which BMPRII selectivity for p55γ could occur. First,
our research revealed BMP2-dependent phosphorylation
of the conserved Tyr199 within iSH2 of p55γ, but not
p85α. Phosphorylation of p55γ iSH2 could induce struc-
tural changes, favouring an association of p55γ with
BMPRII over that of the p85α SH2 domain. Second, the
N-terminal 34 residues of p55γ bind to tubulin [42]. Be-
cause the p55γ N-terminal sequence is unique and not
present in p85α, it was proposed that this interaction spe-
cifically recruits p55γ to the cell periphery [42]. During
onset of cortical actin rearrangements, microtubule plus
ends penetrate the leading edge cytocortex together with
actin nucleating factors [44]. The binding of p55γ to mi-
crotubules, especially at the very tip, could thus provide a
sub-cellular pool of p55γ for signalling involved in cortical
actin-driven lamellipodia formation.
Besides specific functions of the class Ia PI3K regula-
tory subunits, class I catalytic subunits also attract in-
creasing attention to provide non-redundant signalling
functions [14]. The catalytic subunit p110α has been im-
plicated in BMP2-induced PI3K signalling and cell mi-
gration by others using a pharmacological targeting
approach [10]. In line with those observations, we found
that p110α is in complex with p55γ and BMPRII. More-
over, this complex produced PIP3 in a BMP2-dependent
fashion. Thus, we propose that BMP2-induced PI3K sig-
nalling is transduced specifically by the p55γ/p110α class
Ia PI3K complex. This could be of particular importance
for cancer therapy because activating mutations in p110α
are frequently found in human cancers, and p55γ is differ-
entially up-regulated in several tumours, which is sufficient
to stimulate tumour angiogenesis [45]. This, together with
the crucial role of BMP2 in oncogenic transformation
and tumour angiogenesis [46-48], suggests that the p55γ/
p110α complex positively regulates BMP2-induced motil-
ity, chemotaxis, and invasion of endothelial and cancer
cells [9,49,50]. Whether the PI3K p55γ/p110α dimer in-
deed represents an attractive molecular target to interfere
with BMP2-related cancers will require intense investiga-
tions in future.
BMP2-induced PIP3 acts as a cellular compass at the
leading edge and recruits LL5β
Numerous cellular activities have been reported to de-
pend on BMP2-induced PI3K signalling [9-11,51-56].
Most previous studies focused on the role of PI3K-induced Akt activity with Akt being the major PI3K ef-
fector. In the present study, we investigated the role and
function of PIP3 beyond Akt activation and focused on
PIP3 localisation and recruitment of cytoskeletal regula-
tors. We visualised BMP2-dependent PIP3 production in
a spatiotemporal manner to gain further insight into its
function. We found PIP3 became quickly enriched in
BMP2-induced lamellipodia at the cytocortex, especially
in cells that displayed strong PCP, suggesting that PIP3
acts as a cellular compass at the leading edge of migrat-
ing cells. PIP3 recruits PH-domain-containing proteins
that facilitate rearrangements of the actin cytoskeleton
[57]. With this knowledge, we aimed to identify PH-
domain proteins that link BMP2-induced PIP3 to actin
regulators. The BMP2-induced lamellipodia are tightly
cross-linked F-actin networks located at the cytocortex
of the leading edge. During maturation and protrusion,
these actin-rich lamellipodia form broad lamella that
allow for the formation of new adhesion sites [58]. In
agreement with our observations, we identified a specific
interaction of PH-domain protein LL5β with PIP3. LL5β
acts as a highly sensitive PIP3 effector during epidermal
growth factor-induced chemotaxis and lamellipodia for-
mation [17]. It regulates the actin cytoskeleton through
interaction with and co-recruitment of filamin C [19] and
filamin A [17]. Filamins orchestrate cortical actin into
three-dimensional structures by cross-linking of F-actin
filaments [59]. Interestingly, besides tethering filamins,
LL5β also tethers Cytoplasmic linker associated proteins
(CLASPs) to the leading edge [17,18]. CLASPs attach
microtubule tips to the cell cortex, which is important for
microtubule stabilisation and thus PCP. Therefore, our
findings provide evidence that LL5β acts as a BMP2-
dependent multifunctional PIP3-sensing scaffold that
eventually also orchestrates microtubule stabilisation at
the cytocortex and thus links BMP2-dependent actin rear-
rangements to microtubule stabilisation.p55γ and LL5β are required for BMP2-induced migration
and chemotaxis
The potency of BMP2 in stimulating migration of cells
with mesenchymal origin is well known. Here, we raised
the question of whether our findings contribute in par-
ticular to BMP2-induced cortical actin rearrangements,
PCP and chemotaxis. We demonstrated that loss of p55γ
prevents cells from efficient PCP establishment during
wound healing and that knock-down of p55γ or LL5β re-
sulted in impaired BMP2-induced chemotaxis. We there-
fore conclude that the pro-migratory effects of BMP2
are driven by PI3K signalling leading to PIP3-dependent
cytoskeletal actin rearrangements, and result mainly in
directional migration explained by the ‘compass’ function
of PIP3.
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Our molecular findings provide a basis for explaining the
important mechanism of BMP2-induced cortical actin re-
arrangements and chemotaxis, which we have graphically
summarised (Figure 8). The novel in vitro data presented
here close gaps in our current understanding of how
BMP2 gradients influence the cellular cytoskeleton and
hence mesenchymal progenitor cell chemotaxis. Interest-
ingly, PIP3 production increases the efficacy of cells in de-
tecting and processing shallow chemokine gradients [60].
This suggests that the molecular mechanism identified
here is important for mesenchymal progenitor cells that
respond to BMP2 gradients in vivo where they might ori-
ginate from distant locations. To visualise this in vivo in
the context of our novel molecular findings will be the fu-
ture goal and a translation of this knowledge towards the
fields of developmental biology and regenerative medicine
is expected.
Methods
Chemicals, recombinant growth factors and inhibitors
All chemicals were purchased from Sigma Aldrich unless
stated otherwise. Recombinant human BMP2 was kindly
provided by Walter Sebald (University of Würzburg,
Würzburg, Germany). The inhibitor LDN-193189 was a
kind gift from Paul Yu (Harvard Medical School, Boston,
MA, USA) and described elsewhere [61]. LY294002 was
purchased from Cell Signaling Technology (Cell Signal-
ing Technology Inc., Danvers, MA, USA) and PI103 was
purchased from Echelon Bioscience (Echelon Bioscience
Inc., Salt Lake City, USA).
Antibodies
Phospho-specific antibodies, as well as protein- and tag-
specific antibodies, were used and applied as recommended
by the manufacturer. A detailed list of all antibodies used
in this study is provided in Additional file 7.
Cell culture
C2C12 cells and HEK293T cells (both from American
Type Culture Collection) were cultivated in Dulbecco’s
modified Eagle’s Medium (DMEM) (Biochrom GmbH,
Berlin, Germany) supplemented with 10% (v/v) foetal calf
serum and 100 U/ml penicillin/streptomycin. To maintain
highest plasticity, C2C12 cells were kept undifferentiated
and competent for BMP-induced signalling by subculture
conditions that maintained a low density corresponding to
approximately 150,000 cells per 182 cm2. Cells were split
every other day when reaching 30% to 40% confluency
and not used at passages higher than 20. Seeding in higher
densities such as required for scratch wound healing was
performed 12 hours prior to the experiment. C2C12 cells
were transfected 48 hours prior to seeding in six-well
plates with 0.5 to 3 μg plasmid DNA or 50nM siRNA(Dharmacon, GE Healthcare, Lafayette, CO, USA) (see
Additional file 8: Table T1) using Lipofectamine2000 and
Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA,
USA) according to manufacturer’s instructions. HEK293T
cells were transfected using polyethyleneimine and ex-
panded in high glucose (4,500 mg/l glucose) DMEM,
48 hours prior to experiment. All experiments requiring
BMP2 stimulation were conducted after 6 hours starva-
tion in DMEM without serum. Cells were grown on un-
coated cell culture plastic unless stated otherwise.
Expression plasmids
The plasmids encoding human BMPRII-LF-HA or mouse
BMPRIb-HA were described previously [20,62,63]. Single
point mutations used to generate kinase dead receptors
were generated by cyclic mutagenesis PCR as described in
[64]. The construct encoding N-terminal flag-tagged p55γ
was generated by cloning the full-length open reading frame
of mouse p55γ into the TOPO-TA vector (Invitrogen,
Carlsbad, CA, USA) before ligation via EcoRI/NotI into
pcDNA3.1 basic. Cloning primers used in this paper are
available upon request. The construct encoding HA-
tagged p85α was a kind gift from Bart Vanhaesebroeck
(QMUL, London, UK). The construct encoding GFP-
tagged PH-domain of Akt was a kind gift from Kerstin
Danker (Charité Berlin, Germany). All constructs were
verified by DNA sequencing.
Immunoprecipitation assays
Immunoprecipitation of expressed proteins from
HEK293T cells was performed using a modified radio-
immunoprecipitation assay buffer containing 0.5% (w/v)
sodium dodecyl sulphate and 0.1% Nonidet P-40. Immu-
noprecipitation from C2C12 cell extracts was performed
using a modified radio-immunoprecipitation assay with
0.1% sodium dodecyl sulphate and 0.5% Nonidet P-40. A
detailed description of the immunoprecipitation and
immunoblotting procedures can be found in Additional
file 7. PIP bead assay was purchased from Echelon Bio-
science and precipitation was performed according to
manufacturer’s instructions.
Mass spectrometry
Identification of p55γ binding to GST-BMPRII was per-
formed as described in [20]. PIP bead-binding proteins were
identified by matrix-assisted laser desorption ionisation-
time of flight mass spectrometry-based peptide mass finger-
printing as described previously [65].
Scratch wound healing
The scratch wound healing assay was performed using
cell culture inserts (ibidi GmbH) according to the manu-
facturer’s instructions on uncoated tissue culture plastic.
A detailed description of the procedure can be found in
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sured by quantifying the intensity translocation values
for three independent biological replicates per condition
using a selective mask filter (Slidebook).
Boyden chamber assay
The assay was performed in a similar manner to [10] with
a detailed description of the procedure in Additional file 7.
Chemotaxis assays
Two-dimensional chemotaxis was assayed using the
μ-slide chemotaxis chamber system (ibidi GmbH,
Martinsried, Germany) according to accompanying
instructions with the following modifications: 1 day
prior to seeding, chambers were coated with 0.5%
gelatin solution in humidified atmosphere washed for
1 hour and dried at 37°C. Pictures were taken using
a 4× objective in bright field modus. Measurements
were performed using an automated sample table
mounted on an Axiovert 200 M (Carl Zeiss, Jena,
Germany) in combination with Axiovision Mark
&Find tool. Manual cell tracking was performed using
the open source ImageJ plugin Manual tracking v2.0.
Immunofluorescence and live cell imaging
For detection of fluorescent signals, we used the Alexa-
conjugated secondary antibody system (Invitrogen,
Carlsbad, CA, USA) and an inverted fluorescence Axio-
vert 200 microscope (Carl Zeiss, Jena, Germany) equipped
with a live cell imaging heating and CO2 chamber
mounted to a CoolSnapHQ CCD camera (Roper Scien-
tific, Martinsried, Germany). Confocal images were taken
using a Zeiss LSM519 laser scanning confocal using 63×
magnification Plan Apochromat objective. A detailed
description is provided in Additional file 7.
Statistics and bioinformatics
Detailed information and description of statistical ana-
lysis on co-localisation studies, intensity translocation
values, western blot quantification, used databases and
artwork programmes is provided in Additional file 7.
We provide an inventory of supplemental information,
supplemental experimental procedures, supplemental infor-
mation and supplemental references (Additional file 7).
Additional files
Additional file 1: Figure S1. Antibody validation, quantification of
co-localisation and test for BMP2 dependent tyrosine phosphorylation of
endogenous BMPRII.
Additional file 2: Figure S2. BMPRI does not co-immunoprecipitate
with p55γ.
Additional file 3: Figure S3. Knock-down efficiency of si-p55γ.Additional file 4: Figure S4. Wortmannin blocks BMP2 induced
PI3K-Akt signalling.
Additional file 5: Figure S5. Effect of small molecule inhibitors on
signalling, PH-Akt-GFP translocation, phospho-Akt/phospho-PDK1 and
BMPRII localisation.
Additional file 6: Movie.
Additional file 7: Inventory of supplemental information,
supplemental experimental procedures, supplemental references.
Additional file 8: Table T1. siRNA oligo sequences (Dharmacon).
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